Until IMMB gets its filings current, files a 15c211 and completes three years worth of Audits the stock will not be able to trade because it can't get a market maker until they become fully reporting. The only way that they could have avoided this was to get the TEMPORARY SUSPENSION lifter retroactively which they tried and apparently spent time and money pursuing based on the filings.
As best I can tell the company has not made any announcement of their intentions but as I have pointed out they have continued to pursue the phase III testing in the EU which would lead you to believe that they are going to do something with the entity in the future. Especially with the Government reported result of the first wave of Phase III testing being so positive. Can't believe any company would not want to pursue getting the filings done when the seem to be so close to, as best I can tell, the only Immunotherapy treatment addressing the Aids virus with these kinds of results.
Any second year finance student would know the requirements of the SEC and FINRA after not having a market maker for 10 days. Its not a reflection of anything other than, in my opinion, the desire of the regulatory agencies to persuade or encourage sub-penny non-reporting companies to become fully reporting under SEC regulations rather than alternative filing guidelines of the OTC Market. If the 10 day suspension had any teeth the company would have been sanctioned, in my humble opinion.
Regardless this has no relevance to BSSP other than as a distraction.
Squirrel........
Market Data 
Markets 
AI
